The Beauty Health Company (NASDAQ:SKIN) Receives Consensus Rating of "Hold" from Analysts

Key Points

• Beauty Health has a consensus “Hold” rating from seven analysts: five holds, one sell and one buy. The average 12-month price target is $1.375.
• Analysts recently reduced their outlook, including TD Cowen cutting its target to $0.90, while Roth Capital maintained a buy rating but lowered its target to $2.00.
• SKIN opened at $0.69, near its 52-week low of $0.55, and reported quarterly revenue of $72.11 million versus expectations of $74.45 million while posting a $0.02-per-share loss.

The Beauty Health Company (NASDAQ:SKIN - Get Free Report) has been assigned a consensus rating of "Hold" from the seven brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $1.3750.

A number of equities analysts have commented on SKIN shares. Weiss Ratings cut Beauty Health from a "sell (d-)" rating to a "sell (e+)" rating in a report on Thursday, July 23rd. Zacks Research lowered Beauty Health from a "strong-buy" rating to a "hold" rating in a report on Monday, July 20th. TD Cowen lowered their target price on shares of Beauty Health from $1.00 to $0.90 and set a "hold" rating on the stock in a research note on Wednesday, August 12th. Finally, Roth Capital reaffirmed a "buy" rating and set a $2.00 target price (down from $2.50) on shares of Beauty Health in a report on Wednesday, May 20th.

Institutional Trading of Beauty Health

Several large investors have recently bought and sold shares of SKIN. Capricorn Fund Managers Ltd purchased a new position in Beauty Health in the 1st quarter worth approximately $17,270,000. Diversified Trust Co purchased a new stake in shares of Beauty Health in the first quarter valued at approximately $25,000. MTM Investment Management LLC grew its position in shares of Beauty Health by 114.0% in the fourth quarter. MTM Investment Management LLC now owns 26,218 shares of the company's stock valued at $36,000 after purchasing an additional 13,968 shares in the last quarter. Invesco Ltd. increased its holdings in shares of Beauty Health by 6.6% in the second quarter. Invesco Ltd. now owns 98,427 shares of the company's stock valued at $188,000 after purchasing an additional 6,059 shares during the last quarter. Finally, Wells Fargo & Company MN increased its holdings in shares of Beauty Health by 58.4% in the fourth quarter. Wells Fargo & Company MN now owns 129,153 shares of the company's stock valued at $180,000 after purchasing an additional 47,622 shares during the last quarter. Hedge funds and other institutional investors own 93.26% of the company's stock.

Beauty Health Price Performance

SKIN stock opened at $0.69 on Tuesday. The stock has a market capitalization of $89.15 million, a P/E ratio of -3.11 and a beta of 1.00. The firm has a 50-day simple moving average of $0.73 and a 200-day simple moving average of $0.81. The company has a quick ratio of 1.48, a current ratio of 1.76 and a debt-to-equity ratio of 4.36. Beauty Health has a 52 week low of $0.55 and a 52 week high of $2.69.

Beauty Health (NASDAQ:SKIN - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.02) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.02). Beauty Health had a negative net margin of 9.79% and a negative return on equity of 47.83%. The firm had revenue of $72.11 million for the quarter, compared to analyst estimates of $74.45 million. Equities analysts forecast that Beauty Health will post -0.16 earnings per share for the current fiscal year.

Beauty Health Company Profile

Beauty Health Company NASDAQ: SKIN is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health's brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.